Development and Validation of Bio-Plex Pro Human Cancer Biomarker Panel 2

The Centers of Disease Control and Prevention estimates that one in every four death in the US is due to cancer, yet approximately one-third of all cancer cases could be prevented if detected early enough. Thus there is a growing need to develop new tools for the study of cancer biomarkers as indications of disease progression and drug efficacy. Download this application note to learn how Bio-Plex Pro Human Cancer Biomarker Panel 2 was used to quantify biomarkers in various samples including plasma and culture supernatant.